Royal London Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25M | Buy |
99,550
+7,136
| +8% | +$1.78M | 0.05% | 283 |
|
|
2025
Q4 | $25.4M | Buy |
92,414
+40,712
| +79% | +$11.1M | 0.05% | 277 |
|
|
2025
Q3 | $13.6M | Buy |
51,702
+16,598
| +47% | +$4.03M | 0.03% | 393 |
|
|
2025
Q2 | $7.68M | Sell |
35,104
-966
| -3% | -$207K | 0.02% | 480 |
|
|
2025
Q1 | $8.08M | Buy |
36,070
+2,642
| +8% | +$728K | 0.02% | 474 |
|
|
2024
Q4 | $10.9M | Buy |
33,428
+1,368
| +4% | +$431K | 0.03% | 408 |
|
|
2024
Q3 | $9.62M | Buy |
32,060
+454
| +1% | +$139K | 0.02% | 426 |
|
|
2024
Q2 | $10.4M | Sell |
31,606
-273
| -0.9% | -$96.5K | 0.03% | 393 |
|
|
2024
Q1 | $12.6M | Sell |
31,879
-916
| -3% | -$339K | 0.03% | 358 |
|
|
2023
Q4 | $11.5M | Buy |
32,795
+1,515
| +5% | +$536K | 0.03% | 362 |
|
|
2023
Q3 | $11.7M | Buy |
31,280
+3,113
| +11% | +$1.2M | 0.04% | 337 |
|
|
2023
Q2 | $10.8M | Buy |
28,167
+3,290
| +13% | +$1.18M | 0.03% | 350 |
|
|
2023
Q1 | $8.62M | Buy |
24,877
+1,443
| +6% | +$422K | 0.03% | 354 |
|
|
2022
Q4 | $5.52M | Hold |
23,434
| – | – | 0.02% | 431 |
|
|
2022
Q3 | $5.77M | Sell |
23,434
-1,132
| -5% | -$345K | 0.03% | 400 |
|
|
2022
Q2 | $7.44M | Hold |
24,566
| – | – | 0.03% | 358 |
|
|
2022
Q1 | $10.1M | Buy |
24,566
+2,292
| +10% | +$897K | 0.04% | 331 |
|
|
2021
Q4 | $10.4M | Hold |
22,274
| – | – | 0.04% | 335 |
|
|
2021
Q3 | $9.46M | Hold |
22,274
| – | – | 0.04% | 338 |
|
|
2021
Q2 | $8M | Hold |
22,274
| – | – | 0.03% | 378 |
|
|
2021
Q1 | $6.28M | Buy |
22,274
+927
| +4% | +$265K | 0.03% | 425 |
|
|
2020
Q4 | $6.05M | Buy |
21,347
+653
| +3% | +$183K | 0.03% | 383 |
|
|
2020
Q3 | $5.66M | Buy |
+20,694
| New | +$5.48M | 0.03% | 369 |
|
Other funds holding WST
VCM
VPM
GIM
